Lopimune 40 mg and 10 mg CAPSULE (ORAL PELLETS)
PDF Leaflet Revision Date: 13 October 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of HIV-1 infection in combination with other antiretrovirals.
Dosage (summary)
Adults: 400/100 mg twice daily; Children: weight-based dosing.
Special Populations
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy; avoid breastfeeding.
Key Drug Interactions
- CYP3A4 substrates
- Rifampicin
- Colchicine
- PDE5 inhibitors
Contraindications
- Severe hepatic insufficiency
- Hypersensitivity to components
Common side effects
- Diarrhoea
- Nausea
- Vomiting
- Dyslipidaemia
Counselling Points
- Take with food
- Do not chew or crush pellets
- Monitor for liver function abnormalities
Serious warnings
- Risk of pancreatitis
- Increased bleeding in haemophilia
- Immune reactivation syndrome
Important Disclaimer
The Lopimune 40 mg and 10 mg CAPSULE (ORAL PELLETS) professional information leaflet below is the property of Cipla Medpro and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
